Furosemide (Page 4 of 4)

PRINCIPAL DISPLAY PANEL

NDC 50090-0150-0

Packaged by:
A-S Medication Solutions
Libertyville, IL 60048

//medlibrary.org/lib/images-rx/furosemide-52/50090-0150-0-300x130.jpg
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 50090-0152-0

Packaged by:
A-S Medication Solutions
Libertyville, IL 60048

//medlibrary.org/lib/images-rx/furosemide-52/50090-0152-0-300x129.jpg
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 50090-0154-0

Packaged by:
A-S Medication Solutions
Libertyville, IL 60048

//medlibrary.org/lib/images-rx/furosemide-52/50090-0154-0-300x127.jpg
(click image for full-size original)
FUROSEMIDE
furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50090-0152(NDC:0781-1818)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 20 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
STARCH, CORN
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 6mm
Flavor Imprint Code GG21
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50090-0152-0 30 TABLET in 1 BOTTLE None
2 NDC:50090-0152-1 100 TABLET in 1 BOTTLE None
3 NDC:50090-0152-7 200 TABLET in 1 BOTTLE None
4 NDC:50090-0152-8 90 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018569 10/19/1981
FUROSEMIDE
furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50090-0154(NDC:0781-1966)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 40 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
STARCH, CORN
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code GG201
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50090-0154-0 30 TABLET in 1 BOTTLE None
2 NDC:50090-0154-1 100 TABLET in 1 BOTTLE None
3 NDC:50090-0154-2 15 TABLET in 1 BOTTLE None
4 NDC:50090-0154-3 60 TABLET in 1 BOTTLE None
5 NDC:50090-0154-9 90 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018569 10/19/1981
FUROSEMIDE
furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50090-0150(NDC:0781-1446)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 80 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
STARCH, CORN
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 10mm
Flavor Imprint Code GG80
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50090-0150-0 100 TABLET in 1 BOTTLE None
2 NDC:50090-0150-1 30 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018569 10/19/1981
Labeler — A-S Medication Solutions LLC (830016429)
Establishment
Name Address ID/FEI Operations
A-S Medication Solutions LLC 830016429 repack (50090-0150), repack (50090-0152), repack (50090-0154)

Revised: 02/2015 A-S Medication Solutions LLC

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/furosemide-52/page/4/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.